| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.005 |